A practical guide for clinicians who treat patients with amiodarone: 2007.
Amiodarone is commonly used to treat supraventricular and ventricular arrhythmias in various inpatient and outpatient settings. Over- and under-use of amiodarone is common, and data regarding patterns of use are sparse and largely anecdotal. Because of adverse drug reactions, proper use is essential to deriving optimal benefits from the drug with the least risk. This guide updates an earlier version published in 2000, reviews indications for use of amiodarone and recommends strategies to minimize adverse effects. The recommendations included herein are based on the best available data and the collective experience of the member of the writing committee.
Goldschlager
Nora
N
University of California, San Francisco, California, USA. ngoldschlager@medsfgh.ucsf.edu
Epstein
Andrew E
AE
Naccarelli
Gerald V
GV
Olshansky
Brian
B
Singh
Bramah
B
Collard
Harold R
HR
Murphy
Elizabeth
E
D000638:Amiodarone / Q000009:adverse effects / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced; D008297:Male; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*; D017180:Tachycardia, Ventricular / Q000188:drug therapy*; D013959:Thyroid Diseases / Q000139:chemically induced
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone